Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biochim Biophys Acta ; 1852(4): 633-43, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25241263

ABSTRACT

Sporadic inclusion-body myositis (s-IBM) is the most common degenerative muscle disease in which aging appears to be a key risk factor. In this review we focus on several cellular molecular mechanisms responsible for multiprotein aggregation and accumulations within s-IBM muscle fibers, and their possible consequences. Those include mechanisms leading to: a) accumulation in the form of aggregates within the muscle fibers, of several proteins, including amyloid-ß42 and its oligomers, and phosphorylated tau in the form of paired helical filaments, and we consider their putative detrimental influence; and b) protein misfolding and aggregation, including evidence of abnormal myoproteostasis, such as increased protein transcription, inadequate protein disposal, and abnormal posttranslational modifications of proteins. Pathogenic importance of our recently demonstrated abnormal mitophagy is also discussed. The intriguing phenotypic similarities between s-IBM muscle fibers and the brains of Alzheimer and Parkinson's disease patients, the two most common neurodegenerative diseases associated with aging, are also discussed. This article is part of a Special Issue entitled: Neuromuscular Diseases: Pathology and Molecular Pathogenesis.


Subject(s)
Aging , Brain , Muscle Fibers, Skeletal , Myositis, Inclusion Body , Protein Aggregation, Pathological , Proteostasis Deficiencies , Aging/metabolism , Aging/pathology , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Amyloid beta-Peptides , Animals , Brain/metabolism , Brain/pathology , Humans , Muscle Fibers, Skeletal/metabolism , Muscle Fibers, Skeletal/pathology , Myositis, Inclusion Body/metabolism , Myositis, Inclusion Body/pathology , Parkinson Disease/metabolism , Parkinson Disease/pathology , Peptide Fragments , Protein Aggregation, Pathological/metabolism , Protein Aggregation, Pathological/pathology , Protein Biosynthesis , Protein Processing, Post-Translational , Proteostasis Deficiencies/metabolism , Proteostasis Deficiencies/mortality
2.
J Neurosci ; 33(18): 7778-86, 2013 May 01.
Article in English | MEDLINE | ID: mdl-23637170

ABSTRACT

Bovine spongiform encephalopathy (BSE) prions were responsible for an unforeseen epizootic in cattle which had a vast social, economic, and public health impact. This was primarily because BSE prions were found to be transmissible to humans. Other species were also susceptible to BSE either by natural infection (e.g., felids, caprids) or in experimental settings (e.g., sheep, mice). However, certain species closely related to humans, such as canids and leporids, were apparently resistant to BSE. In vitro prion amplification techniques (saPMCA) were used to successfully misfold the cellular prion protein (PrP(c)) of these allegedly resistant species into a BSE-type prion protein. The biochemical and biological properties of the new prions generated in vitro after seeding rabbit and dog brain homogenates with classical BSE were studied. Pathobiological features of the resultant prion strains were determined after their inoculation into transgenic mice expressing bovine and human PrP(C). Strain characteristics of the in vitro-adapted rabbit and dog BSE agent remained invariable with respect to the original cattle BSE prion, suggesting that the naturally low susceptibility of rabbits and dogs to prion infections should not alter their zoonotic potential if these animals became infected with BSE. This study provides a sound basis for risk assessment regarding prion diseases in purportedly resistant species.


Subject(s)
Disease Susceptibility , Encephalopathy, Bovine Spongiform/metabolism , Encephalopathy, Bovine Spongiform/transmission , Prions/metabolism , Proteostasis Deficiencies/etiology , Animals , Brain/metabolism , Brain/pathology , Cattle , Disease Models, Animal , Dogs , Encephalopathy, Bovine Spongiform/mortality , Humans , Mice , Mice, Transgenic , Nucleic Acid Amplification Techniques/methods , Proteostasis Deficiencies/mortality , Proteostasis Deficiencies/pathology , Rabbits , Species Specificity , Survival Analysis
3.
Eur J Histochem ; 57(1): e5, 2013 Mar 07.
Article in English | MEDLINE | ID: mdl-23549464

ABSTRACT

Formation, aggregation and transmission of abnormal proteins are common features in neurodegenerative disorders including Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and Huntington's disease. The mechanisms underlying protein alterations in neurodegenerative diseases remain controversial. Novel findings highlighted altered protein clearing systems as common biochemical pathways which generate protein misfolding, which in turn causes protein aggregation and protein spreading. In fact, proteinaceous aggregates are prone to cell-to-cell propagation. This is reminiscent of what happens in prion disorders, where the prion protein misfolds thus forming aggregates which spread to neighbouring cells. For this reason, the term prionoids is currently used to emphasize how several misfolded proteins are transmitted in neurodegenerative diseases following this prion-like pattern. Histochemical techniques including the use of specific antibodies covering both light and electron microscopy offer a powerful tool to describe these phenomena and investigate specific molecular steps. These include: prion like protein alterations; glycation of prion-like altered proteins to form advanced glycation end-products (AGEs); mechanisms of extracellular secretion; interaction of AGEs with specific receptors placed on neighbouring cells (RAGEs). The present manuscript comments on these phenomena aimed to provide a consistent scenario of the available histochemical approaches to dissect each specific step.


Subject(s)
Cell Communication , Glycation End Products, Advanced/metabolism , Neurodegenerative Diseases/mortality , Prions/metabolism , Protein Folding , Proteostasis Deficiencies/mortality , Animals , Humans , Neurodegenerative Diseases/pathology , Prions/pathogenicity , Proteostasis Deficiencies/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...